Breaking News, Promotions & Moves

BioNTech Appoints Annemarie Hanekamp Chief Commercial Officer

Annemarie joins the company from Novartis and brings more than 20 years of experience in the healthcare industry.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioNTech SE has appointed Annemarie Hanekamp to the Management Board as Chief Commercial Officer effective July 1, 2024. She will join BioNTech from Novartis succeeding Sean Marett in this role.   Annemarie Hanekamp is a seasoned pharmaceutical executive experienced in developing patient-focused commercial strategies for innovative oncology products encompassing sales, marketing and market access. In her new role, she will drive the company’s global commercialization strategy. Annemarie Haneka...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters